Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

SHA:600721 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.61	272.05	202.07	135.73	86.88	45.62
Trading Asset Securities	177.85	-	-	-	-	10
Cash & Short-Term Investments	245.46	272.05	202.07	135.73	86.88	55.62
Cash Growth	19.40%	34.63%	48.88%	56.22%	56.22%	-42.14%
Accounts Receivable	217.31	202.04	217.65	204.24	167.04	174.17
Other Receivables	4.69	6.45	6.18	3.95	7.94	9.95
Receivables	222	208.48	223.82	208.19	174.98	184.12
Inventory	104.43	99.72	124.83	149.43	194.05	188.37
Other Current Assets	10.12	3.02	14.04	12.32	12.18	12.36
Total Current Assets	582.02	583.27	564.77	505.67	468.09	440.46
Property, Plant & Equipment	141.25	140.11	138.19	147.8	161.64	181.89
Long-Term Investments	63.77	63.77	63.7	60.74	58.51	61.7
Goodwill	11.49	11.49	11.49	11.49	11.49	11.49
Other Intangible Assets	7.96	8.41	10.07	11.49	11.67	12.46
Long-Term Deferred Tax Assets	31.79	31.78	14.82	15.4	14.94	15.49
Long-Term Deferred Charges	33.9	30.19	13.47	4.17	4.68	3.83
Other Long-Term Assets	249.11	245.53	245.51	244.93	251.29	247.37
Total Assets	1,121	1,115	1,062	1,002	982.31	974.68
Accounts Payable	91.21	86.65	100.73	92.82	58.39	49.96
Accrued Expenses	15.59	29.57	29.15	26.8	25.18	23.04
Short-Term Debt	-	-	-	-	6.3	-
Current Portion of Leases	0.04	0.1	0.44	0.51	-	-
Current Income Taxes Payable	3.38	1.78	1.45	1.22	1.17	1.91
Current Unearned Revenue	134.8	140.51	111.27	98.85	85.73	94.75
Other Current Liabilities	49.09	50.51	65.4	69	77.11	138.57
Total Current Liabilities	294.11	309.12	308.44	289.2	253.89	308.24
Long-Term Leases	-	-	1.13	1.82	-	-
Long-Term Unearned Revenue	1.01	1.06	1.81	2.35	3.02	3.79
Long-Term Deferred Tax Liabilities	44.04	43.52	42.09	39.8	36.88	34.25
Other Long-Term Liabilities	1.1	1.1	1.1	0.5	1.39	3.2
Total Liabilities	341.42	355.96	355.39	334.66	296.06	350.52
Common Stock	384.14	384.03	381.69	377.67	375.13	375.13
Additional Paid-In Capital	2,266	2,266	2,258	2,235	2,217	2,214
Retained Earnings	-1,878	-1,898	-1,940	-1,953	-1,918	-1,978
Comprehensive Income & Other	7.2	7.2	7.29	7.43	7.66	7.85
Total Common Equity	779.86	758.58	706.62	667.01	681.3	619.26
Minority Interest	-	-	-	-	4.95	4.9
Shareholders' Equity	779.86	758.58	706.62	667.01	686.25	624.16
Total Liabilities & Equity	1,121	1,115	1,062	1,002	982.31	974.68
Total Debt	0.04	0.1	1.57	2.33	6.3	-
Net Cash (Debt)	245.42	271.95	200.5	133.4	80.59	55.62
Net Cash Growth	20.27%	35.64%	50.29%	65.54%	44.90%	-26.94%
Net Cash Per Share	0.64	0.71	0.53	0.35	0.21	0.14
Filing Date Shares Outstanding	384.14	384.03	381.69	377.67	375.13	375.13
Total Common Shares Outstanding	384.14	384.03	381.69	377.67	375.13	375.13
Working Capital	287.91	274.15	256.33	216.47	214.21	132.22
Book Value Per Share	2.03	1.98	1.85	1.77	1.82	1.65
Tangible Book Value	760.42	738.68	685.06	644.04	658.14	595.31
Tangible Book Value Per Share	1.98	1.92	1.79	1.71	1.75	1.59
Buildings	-	161.92	161.92	161.73	158.52	158.52
Machinery	-	174.08	158.62	150.41	146.97	143.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.